Incyte to Present at the 2010 Bank of America Merrill Lynch Health Care Conference
May 03 2010 - 4:15PM
Business Wire
Incyte Corporation (Nasdaq:INCY) announced today it will present
at the 2010 Bank of America Merrill Lynch Health Care Conference on
Wednesday, May 12, 2010 at 1:40 p.m. ET. Presenting for Incyte
Corporation will be Paul Friedman, M.D., president and chief
executive officer.
The presentation will be webcast live and can be accessed at
www.incyte.com under Investor Relations, Events and Webcasts. A
replay of the presentation will be available for 30 days. Investors
interested in listening to the live webcast should log on before
the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based drug
discovery and development company focused on developing proprietary
small molecule drugs for oncology and inflammation. Incyte's most
advanced compound, INCB18424, is in Phase III development for
myelofibrosis. For additional information on Incyte, visit the
Company's web site at www.incyte.com.
Incyte (NASDAQ:INCY)
Historical Stock Chart
From May 2024 to Jun 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jun 2023 to Jun 2024